2005
DOI: 10.1016/j.pediatrneurol.2005.02.015
|View full text |Cite
|
Sign up to set email alerts
|

An Updated Review of the Long-Term Neurological Effects of Galactosemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
77
1
2

Year Published

2006
2006
2017
2017

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 102 publications
(83 citation statements)
references
References 83 publications
3
77
1
2
Order By: Relevance
“…5 Despite early dietary management, chronic complications such as intellectual deficits, ataxia, speech dyspraxia, premature ovarian insufficiency (POI) and decreased bone mineralization occur in many adults. [10][11][12][13][14][15][16][17][18][19] Different cell and animal models have been utilized to understand the pathogenic mechanisms of the acute neonatal lethality and the long-term complications associated with Classic Galactosemia. Early genetic studies in the yeast Saccharomyces cerevisiae showed that GALT-deficient mutant yeasts are sensitive to galactose in growth medium; but disruption of galactokinase (GALK) function in these yeasts reversed their galactose sensitivity.…”
Section: Introductionmentioning
confidence: 99%
“…5 Despite early dietary management, chronic complications such as intellectual deficits, ataxia, speech dyspraxia, premature ovarian insufficiency (POI) and decreased bone mineralization occur in many adults. [10][11][12][13][14][15][16][17][18][19] Different cell and animal models have been utilized to understand the pathogenic mechanisms of the acute neonatal lethality and the long-term complications associated with Classic Galactosemia. Early genetic studies in the yeast Saccharomyces cerevisiae showed that GALT-deficient mutant yeasts are sensitive to galactose in growth medium; but disruption of galactokinase (GALK) function in these yeasts reversed their galactose sensitivity.…”
Section: Introductionmentioning
confidence: 99%
“…Research to date suggests that differential developmental outcomes observed in the disorder are not related to conditions during the neonatal (e.g., age at diagnosis and restriction of galactose intake or severity of neonatal crisis) or postnatal period [e.g., adherence to diet] (Cleary et al 1995;Bosch 2011). Rather, developmental outcome may be influenced by prenatal conditions (Fridovich andWalter 2008, Potter et al 2008;Berry and Elsas 2011) such as harmful intrauterine levels of galactitol causing early but static neural injury (Ridel et al 2005). Exposure to galactose in the neonatal period may magnify the galactose toxicity in individual children (Berry and Elsas 2011).…”
Section: Discussionmentioning
confidence: 99%
“…GAL is the result of an inborn deficiency of the enzyme galactose-1-phosphate uridyltransferase [GALT] (Bosch 2006). Approximately one child in 53,000 in the United States is born with the disorder (Ridel et al 2005). Intervention for galactose toxicity is the implementation of a galactoserestricted diet (Hughes et al 2009).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Consumption of fruits and vegetables containing galactose is still a controversy [Bosch, 2006]; however, endogenous production of galactose may account for elevated galactose metabolites in galactosemic patients under strict diets [Berry et al, 1993;Segal, 1998]. Despite treatment, patients with classical galactosemia may experience long-term complications such as cognitive and developmental delays, and ovarian failure [Fishler et al, 1980;Friedman et al, 1989;Waggoner et al, 1990;Leslie et al, 1992;Waggoner and Buist, 1993;Kaufman et al, 1995;Lewis et al, 1995;Nelson, 1995;Leslie, 2003;Ridel et al, 2005]. Consequently, the speed at which diagnosis and treatment are implemented may influence the long-term outcome of a galactosemic patient.…”
Section: Introductionmentioning
confidence: 99%